Home › Peripheral Arterial Disease › Virginia › Richmond
Peripheral Arterial Disease clinical trials in Richmond, VA
4 studies for Peripheral Arterial Disease are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
RecruitingPhase 3
- Clinical Research Partners, LLC, Richmond
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Richmond V.A. Medical Center, Richmond
Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation
Recruiting
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RecruitingPhase 4
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Chicago, IL9 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Boston, MA9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Omaha, NE7 studies
- Nashville, TN6 studies
- Aurora, CO6 studies
- Minneapolis, MN6 studies
- Miami, FL6 studies
- Norfolk, VA5 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Cardiovascular Disease13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Metastatic Cancer12 studies
- Melanoma11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.